MARKET

SENS

SENS

SENSEONICS
AMEX

Real-time Quotes | Nasdaq Last Sale

0.3755
-0.0041
-1.08%
After Hours: 0.3800 +0.0045 +1.20% 16:12 09/23 EDT
OPEN
0.3800
PREV CLOSE
0.3796
HIGH
0.3800
LOW
0.3615
VOLUME
1.08M
TURNOVER
--
52 WEEK HIGH
1.780
52 WEEK LOW
0.3600
MARKET CAP
85.47M
P/E (TTM)
-0.7141
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
DexCom: A Superior Business Model But Watch Out For Debt Level
DexCom produces continuous glucose monitoring devices.The stock price has increased steeply in the last one year, but a slight dip recently constitutes an opportunity for investors.The medical devices company has enjoyed double-digit growth and looks likely to continue when considering the business model.It has a high level of product differentiation compared with competitors but debt level is also higher.The stock has the potential to climb much higher.
Seekingalpha · 3d ago
These 3 Penny Stocks Could Double (Or More), Says BTIG
After an epic rally to all-time highs, the stock market has been seesawing between the red and the green. The volatility that has ensued wasn’t driven by overtly negative news; progress on a COVID-19 vaccine is being made and economic data has been better-than-expected.BTIG’s Julian Emanuel argues that
TipRanks · 09/14 15:20
Senseonics Announces Analyst and Investor Event on September 15, 2020
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to host a virtual analyst and investor event on Tuesday,
Business Wire · 09/08 22:30
Do Options Traders Know Something About Senseonics (SENS) Stock We Don't?
Investors need to pay close attention to Senseonics (SENS) stock based on the movements in the options market lately.
Zacks · 09/03 13:33
Local Coverage Determinations for Implantable CGMs Announced by Three Medicare Administrative Contractors
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that three Medicare Administrative Contractors (MACs) have issued
Business Wire · 09/01 13:00
Senseonics Announces Medicare Administrative Contractors Have Issued Local Coverage Determinations For Use Of Implantable CGM Systems Such As Eversense CGM System
Positive Implantable CGM Coverage Policy Criteria Lessens Burdens to Patient Access Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and commercialization of long-term,
Benzinga · 09/01 12:17
Senseonics shares are trading higher after the company reported better-than-expected Q2 EPS results. BTIG and Craig-Hallum also upgraded the stock.
Benzinga · 08/11 13:30
Senseonics Holdings (SENS) Reports Break-Even Earnings for Q2
Senseonics (SENS) delivered earnings and revenue surprises of 100.00% and -76.27%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 08/10 23:55
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of SENS. Analyze the recent business situations of SENSEONICS through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average SENS stock price target is 0.9300 with a high estimate of 1.250 and a low estimate of 0.4000.
EPS
Institutional Holdings
Institutions: 117
Institutional Holdings: 93.52M
% Owned: 40.39%
Shares Outstanding: 231.56M
TypeInstitutionsShares
Increased
49
4.74M
New
13
3.28M
Decreased
18
5.37M
Sold Out
21
1.58M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-3.26%
Pharmaceuticals & Medical Research
-1.30%
Key Executives
Chairman/Independent Director
Stephen DeFalco
President/Chief Executive Officer/Director
Timothy Goodnow
Chief Financial Officer/Treasurer/Secretary
Nick Tressler
Chief Operating Officer
Mukul Jain
Vice President/General Manager
Mirasol Panlilio
Other/Director
Francine Kaufman
Independent Director
Steven Edelman
Independent Director
Edward Fiorentino
Independent Director
Peter Klein
Independent Director
Douglas Prince
Independent Director
Douglas Roeder
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About SENS
Senseonics Holdings, Inc. is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes. The Company's Eversense system consists of components, such as a sensor, which is inserted subcutaneously in the upper arm by a healthcare provider; an external removable smart transmitter that receives, assesses and relays the data from the sensor and also provides vibratory alerts, and a mobile application that receives data from the transmitter and provides real-time glucose readings, alerts and other data on the user's mobile device, such as a smartphone, Apple Watch or tablet.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Senseonics Holdings Inc stock information, including AMEX:SENS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SENS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SENS stock methods without spending real money on the virtual paper trading platform.